The Multibillion-Dollar Market Corporate America Is Missing Out On
3 minute readPublished: Thursday, May 15, 2025 at 10:45 am

The $360 Billion Women's Health Market Corporate America is Missing
Forget crypto and AI – a massive, untapped market is ripe for investment, and it's focused on women's health. A recent report by Amboy Street Ventures, dubbed the "Ghost Market Report," estimates this sector's potential value at a staggering $360 billion in the U.S. This "ghost market" represents areas of women's health that are currently underserved and lacking sufficient investment.
The report highlights several key categories with significant unmet needs, including menopause, healthy aging, sexual health, menstruation, contraception, LGBTQ+ health, maternal health, and fertility. The report underscores a critical gap between the healthcare women need and the services available. While women require nearly 10% more healthcare services than men, only about 4% of biopharma research and development spending is dedicated to women-specific conditions.
This lack of investment is compounded by potential headwinds. Recently announced tariffs could increase the cost and scarcity of medical supplies, potentially hindering progress in this burgeoning market.
However, there's also positive momentum. The Milken Institute is launching a Women's Health Network, chaired by former First Lady Jill Biden, to foster collaboration and advance women's health initiatives. This network aims to bring together researchers, startups, investors, and policymakers to drive progress.
The report also points out the potential for career advancement for women in healthcare. Women already make up the majority of healthcare workers, and this market presents opportunities for them to lead companies and create new sectors. Investing in women's health is not only a financial opportunity but also a moral imperative, potentially improving health outcomes for millions.
BNN's Perspective: This report highlights a significant market opportunity that has been historically overlooked. While the potential for financial returns is undeniable, the ethical considerations are equally important. Addressing the unmet needs in women's health is crucial for creating a more equitable healthcare system. The focus on collaboration and investment, as championed by the Milken Institute, is a positive step forward. However, the impact of tariffs on medical supply costs needs to be carefully monitored to ensure progress isn't hampered.
Keywords: women's health, ghost market, investment, healthcare, menopause, fertility, maternal health, sexual health, LGBTQ+ health, Amboy Street Ventures, Milken Institute, Jill Biden, healthcare market, underserved, biopharma, tariffs, medical supplies, healthcare for women, women's health initiatives, healthcare equity